These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28617240)

  • 1. What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial.
    Shinkins B; Nicholson BD; James T; Pathiraja I; Pugh S; Perera R; Primrose J; Mant D
    Health Technol Assess; 2017 Apr; 21(22):1-60. PubMed ID: 28617240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.
    Mant D; Gray A; Pugh S; Campbell H; George S; Fuller A; Shinkins B; Corkhill A; Mellor J; Dixon E; Little L; Perera-Salazar R; Primrose J
    Health Technol Assess; 2017 May; 21(32):1-86. PubMed ID: 28641703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: Results from the FACS trial.
    Shinkins B; Nicholson BD; Primrose J; Perera R; James T; Pugh S; Mant D
    PLoS One; 2017; 12(3):e0171810. PubMed ID: 28282381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.
    Shinkins B; Primrose JN; Pugh SA; Nicholson BD; Perera R; James T; Mant D
    Br J Surg; 2018 May; 105(6):658-662. PubMed ID: 29579327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood CEA levels for detecting recurrent colorectal cancer.
    Nicholson BD; Shinkins B; Pathiraja I; Roberts NW; James TJ; Mallett S; Perera R; Primrose JN; Mant D
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011134. PubMed ID: 26661580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.
    Primrose JN; Perera R; Gray A; Rose P; Fuller A; Corkhill A; George S; Mant D;
    JAMA; 2014 Jan; 311(3):263-70. PubMed ID: 24430319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer.
    Fernandes LC; Kim SB; Saad SS; Matos D
    World J Gastroenterol; 2006 Jun; 12(24):3891-4. PubMed ID: 16804977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic accuracy of carcinoembryonic antigen to detect colorectal cancer recurrence - A systematic review.
    Sørensen CG; Karlsson WK; Pommergaard HC; Burcharth J; Rosenberg J
    Int J Surg; 2016 Jan; 25():134-44. PubMed ID: 26700203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoural immune signature to identify patients with primary colorectal cancer who do not require follow-up after resection: an observational study.
    Primrose JN; Pugh SA; Thomas G; Ellis M; Moutasim K; Mant D
    Health Technol Assess; 2021 Jan; 25(2):1-32. PubMed ID: 33416473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer.
    Tan E; Gouvas N; Nicholls RJ; Ziprin P; Xynos E; Tekkis PP
    Surg Oncol; 2009 Mar; 18(1):15-24. PubMed ID: 18619834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer.
    McCall JL; Black RB; Rich CA; Harvey JR; Baker RA; Watts JM; Toouli J
    Dis Colon Rectum; 1994 Sep; 37(9):875-81. PubMed ID: 8076486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis.
    Körner H; Söreide K; Stokkeland PJ; Söreide JA
    Ann Surg Oncol; 2007 Feb; 14(2):417-23. PubMed ID: 17103264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
    Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
    Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Measurement of Carcinoembryonic Antigen Level for Detecting Recurrence of Colorectal Cancer.
    Nicholson BD; Shinkins B; Mant D
    JAMA; 2016 Sep; 316(12):1310-1. PubMed ID: 27673308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of recurrences during follow-up after liver surgery for colorectal metastases: both carcinoembryonic antigen (CEA) and imaging are important.
    Verberne CJ; Wiggers T; Vermeulen KM; de Jong KP
    Ann Surg Oncol; 2013 Feb; 20(2):457-63. PubMed ID: 22948771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels - An analysis within the COLOFOL randomized clinical trial.
    Egenvall M; Martling A; Veres K; Horváth-Puhó E; Wille-Jørgensen P; Høirup Petersen S; Laurberg S; Sørensen HT; Syk I;
    Eur J Surg Oncol; 2021 Aug; 47(8):2053-2059. PubMed ID: 33846037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic Antigen (CEA) measurements and CEA-triggered imaging: Results of the randomized "CEAwatch" trial.
    Verberne CJ; Zhan Z; van den Heuvel E; Grossmann I; Doornbos PM; Havenga K; Manusama E; Klaase J; van der Mijle HC; Lamme B; Bosscha K; Baas P; van Ooijen B; Nieuwenhuijzen G; Marinelli A; van der Zaag E; Wasowicz D; de Bock GH; Wiggers T
    Eur J Surg Oncol; 2015 Sep; 41(9):1188-96. PubMed ID: 26184850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling of serial carcinoembryonic antigen changes in colorectal cancer.
    Carl J; Bentzen SM; Nørgaard-Pedersen B; Kronborg O
    Scand J Clin Lab Invest; 1993 Nov; 53(7):751-5. PubMed ID: 8272763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan.
    Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH
    Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
    Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
    Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.